How Is Campbell's Stock Performance Compared to Other Food & Beverage Stocks?
Company Overview: The Campbell's Company, valued at $11.7 billion, is a major player in the food and beverage industry with a diverse portfolio of well-known brands, but has experienced a significant decline in stock performance over the past year and underperformed compared to its peers.
Recent Financial Performance: Despite a revenue increase driven by acquisitions, Campbell's reported mixed Q2 earnings, lowered its full-year guidance, and analysts maintain a cautious outlook with a consensus rating of "Hold" and a modest price target suggesting limited upside.
Trade with 70% Backtested Accuracy
Analyst Views on GIS
About GIS
About the author

- Sustainable Agriculture Progress: General Mills is advancing regenerative agriculture on over 800,000 acres, nearing its 2030 commitment, which enhances its leadership in sustainability and attracts environmentally conscious consumers.
- Food Safety Commitment: The company plans to remove certified colors from U.S. cereals and K-12 school foods by summer 2026, achieving the K-12 goal ahead of schedule, thereby enhancing product safety and consumer trust.
- Community Contributions: General Mills contributed over $83 million in food and charitable donations globally, enabling more than 7.9 billion meals, which strengthens its image in social responsibility and fosters good community relations.
- Employee Satisfaction Improvement: With 86% of employees rating General Mills as a great place to work and 82% feeling a strong sense of belonging, this not only boosts employee morale but also creates higher productivity and innovation for the company.

- Price Target Increase: Morgan Stanley raised Gilead's (GILD) price target from $171 to $175, reflecting an optimistic outlook on the company's future performance, which is expected to boost investor confidence and potentially drive the stock price higher.
- Rating Maintained: The firm continues to assign an Overweight rating to Gilead, indicating analysts' recognition of its long-term growth potential, which may attract more institutional investors to the stock.
- Model Adjustments: Morgan Stanley adjusted its models across its biopharma coverage to reflect IQVIA trends and intra-quarter updates, demonstrating keen insights into industry dynamics that will aid in more accurately forecasting the company's performance.
- Market Reaction Anticipation: With the first-quarter earnings report approaching, the heightened market focus on Gilead, combined with the analysts' positive rating and price target increase, is likely to stimulate stock price appreciation ahead of the earnings release, enhancing market confidence in its future performance.
- Dividend Durability: Despite short-term earnings pressure, General Mills (GIS) maintains a 127-year uninterrupted dividend payment history, currently yielding 6.7%, making it highly attractive for long-term income investors within the S&P 500.
- Brand Resilience: Hormel Foods (HRL) has raised its dividend for 59 consecutive years, and despite a 50% drop in share price since April 2022, its brands like Spam and Skippy remain market leaders, showcasing strong brand resilience and adaptability.
- Market Potential: Kenvue (KVUE), spun off from Johnson & Johnson in 2023, has seen its stock price drop about 30%, yet its product portfolio including Tylenol and Listerine shows a 3.2% revenue growth quarter-over-quarter, indicating defensibility and growth potential in consumer health.
- E-commerce Penetration: Church & Dwight (CHD) has achieved a 23% e-commerce channel share in global sales, with brands like Arm & Hammer contributing 70% of revenue, and is guiding for 3% to 4% organic sales growth in 2026, highlighting strong market prospects and investment value.
- Market Confidence Decline: The consumer confidence index has dropped to 56.4, nearing recession levels, prompting a shift towards defensive businesses, and despite flat performance in consumer staples in 2025, there are opportunities to buy at low prices.
- General Mills' Investment Value: General Mills (GIS) is trading at a 15-year low with a year-to-date decline of about 21%, yet its 127-year uninterrupted dividend history and a 6.7% yield make it a reliable choice for long-term passive income.
- Hormel Foods' Resilience: Hormel Foods (HRL) has raised its dividend for 59 consecutive years, and despite a 50% drop from its 2022 peak, its brand leadership and dual position in private-label manufacturing provide a defensive edge.
- Kenvue's Market Potential: Kenvue (KVUE), spun off from Johnson & Johnson, is down 30% from its 52-week high, but its stable product portfolio and analyst support make it an investment worth considering.
- General Mills' Struggles: General Mills (NYSE: GIS) is trading at a 15-year low, having fallen over 50% in the past three years and approximately 21% year-to-date in 2026, despite a high dividend yield of 6.7%; however, with North American organic sales down 3% and adjusted operating profit down 32% in the latest quarter, the company faces short-term challenges, although its Blue Buffalo pet food segment shows double-digit growth in select categories, indicating long-term investment potential.
- Hormel Foods' Discount Opportunity: Hormel Foods (NYSE: HRL) has raised its dividend for 59 consecutive years, making it a Dividend King with a current yield above 5%, yet its stock price has dropped about 50% since its peak in April 2022 due to challenges like a chicken recall and a plant fire; nevertheless, its brands like Spam and Skippy remain market leaders, and its private-label business can offset declines in branded sales during economic downturns, showcasing unique market resilience.
- Kenvue's Potential: Kenvue (NYSE: KVUE), spun off from Johnson & Johnson, owns well-known brands like Tylenol and Listerine, trading near $17.50 with a dividend yield approaching 4.8%, and despite being down roughly 30% from its 52-week high, it reported a 3.2% revenue growth quarter-over-quarter, with analysts maintaining a positive outlook, highlighting its defensible product portfolio in consumer health.
- Church & Dwight's Steady Growth: Church & Dwight (NYSE: CHD) is the world's largest producer of baking soda, and while it lacks brand recognition, its brands like Arm & Hammer and OxiClean account for about 70% of revenue; the company recently acquired Touchland's hand sanitizer business and is guiding for 3% to 4% organic sales growth in 2026, demonstrating strong performance in e-commerce and long-term growth potential.

General Mills Filing: General Mills has filed a pricing terms sheet for the offering of two-part euro-denominated notes.
Offering Amount: The total amount for the notes being offered is up to €1.7 billion.









